DRKS00010070已完成不适用
Cohort Study to Assess the Impact of CYP2D6 Genotype on the Efficacy ofClomiphene - IKP245
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 161
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 40 Years（—）
- 性别
- Female
入选标准
- •1. Written informed consent obtained prior to study entry including informed consent for genetic Research
- •2. Aged 18 to 40 years
- •3. BMI 18.5 kg/m² - 26 kg/m²
- •4. Minimum of one planned or done clomiphene therapy cycle
排除标准
- •1. Concomitant treatment with other ovulation inducing medication (e.g FSH, LHRH-analogue; induction of ovulation by hCG is allowed)
- •2. Unwillingness to provide informed consent of the study
研究者
相似试验
Unknown
不适用
CYP2D6 Genotype on the Clinical Effect of TamoxifenBreast NeoplasmsTamoxifenGenotypeCYP2D6NCT00973037Korea University Anam Hospital922
已完成
不适用
Relationships between genetic variability and plasma donepezil levels in Thai patients with dementiaDonepezilCYP2D6DementiaTCTR20190924003Faculty of Medicine, Chulalongkorn Unviersity120
Unknown
不适用
Genotyping and Phenotyping of CYP2D6 Breast Cancer Patients on TamoxifenBreast Cancer FemaleNCT03504631Trisakti University117
终止
2 期
Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of TamoxifenMetastatic DiseaseBreast CancerNCT00532454National Cancer Center, Korea21
进行中（未招募）
不适用
CYP2D6 gene as a biomarker for predicting the dose of ondansetron for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomyCTRI/2021/08/035812niversity College of Medical Sciences and GTB Hospital